Chenglong He

Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer

Cheng Chen, X. Chu, Huiyu Li, 2021, Frontiers in Oncology.

Long non‐coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression

D. Yan, B. Yue, Chenglong He, 2017, Journal of gastroenterology and hepatology.

PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2

Lijun Xue, Cheng Chen, Tingting Dai, 2021, Molecular therapy. Nucleic acids.

CRISPR screen in cancer: status quo and future perspectives.

Cheng Chen, X. Chu, Mei-juan Wu, 2021, American journal of cancer research.

Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer

Cheng Chen, Ze-tian Shen, Xi-Xu Zhu, 2021, Frontiers in Oncology.

Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes

Cheng Chen, Longwei Jiang, X. Chu, 2021, Frontiers in Molecular Biosciences.

The functions and prognostic values of chemokine and chemokine receptors in gastric cancer.

Liping He, Chenglong He, Wenjing Dong, 2022, American journal of cancer research.